Publications (0ct 2022 to Sept 2023)
1. Paul R, Ghosh A, Sengupta N, Sahana PK. Comparison of eficacy and safely of vildagliptin 50 mg tablet twice daily and vildagliptin 100 mg sustained release once daily tablet on top of metformin in Indian patients with Type 2 diabetes mellitus: A randomized, open label, Phase IV parallel group, clinical trial. Natl JPhysiol Pharm Pharmacol 2022;12(08):1229-1232.
2. Das N, Sahana PK, Tarenia SS, Gaikwad PM, Baidya A, Goswami S, SenguptaN et al. Osteopetrosis: A rare case. Ann Med Sci Res 2022:1:93-6.
3. Hathi D, Goswami S, Sengupta N, et al. (September 16, 2022) A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate. Cureus 14(9): e29234.
4. Goswami S, Gupta U, Sengupta N, Sahana PK, and Baidya A. Vitamin D Status and its Relation to Obesity in Adolescent Schoolgirls in Kolkata-An Epidemiological Pilot Study. Ann Adv Biomed Sci 2022, 5(2):000193
5. Baidya A, Basu A, Bhattacharjee R, Biswas D, Biswas K, Chakraborty P Chatterjee P Chowdhury S, Dasgupta R, Ghosh A, Ghosh S, Giri D, Goswami S, Maisnam 1, Maiti A, Mondal S, Mukhopadhyay p Mukhopadhyay S, Mukhopadhyay S, Pal S, Pandit K, Ray S, Chowdhury B, Raychaudhuri M Raychaudhuri P, Roy A, Sahana P Sanyal D, Sanyal T, Saraogi R, Sarkar D, Sengupta N, Singh A, Sinha A Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement. Journal of Pediatric Endocrinology and Metabolism. 2022. https://doi.org/10.1515/jpem-2022-0515.
6. Soumik G, Deep H, Atma Prakash N, Manish J. Risk factors and salient features of Acute Kidney Injury in Diabetic Ketoacidosis. J Endocrinol Thyroid Res. 2022;7(1):555703.
7. Tarenia S, Chattopadhyay S, Niladri Das, Hathi D, Baidya A, Chakrabarty P Sengupta N, & Goswami S (2022). Swyer Syndrome Presenting as Dysgerminoma: A Case Report Journal of the ASEAN Federation of Endocrine Societies, 38(1), 108-113. https://doi.org/10.15605/jafes.038.01.15.
8. Ghosh S, Yasmin M, Sen K, Goswami S, Das TC, Swar SC, et al. Integrated care for type 1 diíabetes: The West Bengal model. Indian J Endocr Metab 0;0:0.
9. Arindam Ray, Pranab Kumar Sahana, Nilanjan Sengupta, Arjun Baidya, Soumik Goswami, Sreenath R. Efficacy And Safety Of Canagliflozin Compared With Linagliptin In Indian Patiets With Type-2 Diabetes Mellitus Inadequately Controlled On Metformin: An Open Label, Randomized Study. Global journal For Research Analysis June 2023;12(6):170-174.
10.Goswami S, Chattopadhyay M. A mini-review in thyroid function test: more than meets our eye. Avicenna J Med Biochem. 2023; 11(1):88-91.
11.Hanumanthu A, Goswami S, Thimmegowda KB, Sengupta N, Baidya A, Sahana PK. A Study On The Prevalence Of Vitamin B12 Deficiency In Eastern Indian Type 2 Diabetes Mellitus Patients With Peripheral Neuropathy On Metformin Presenting To A Tertiary Care Hospital. Digital Journal of Clinical Medicine. 2023; 5(3): 102-113. doi: https://doi. org/10.55691/2582-3868.1138.
12. Mahapatra U, Singh DJ, Datta J, Seth BC, Mandal PK, Kar JK. Clinico-epidemiological Profile of Snake Bite in a Rural Tertiary Care Hospital of West Bengal. J Indian Med Assoc 2023; 121(9): 44-9.
13. Baidya A, Mishra S, Venkatanarasu A. VWill Oral Semaglutide be a Game-Changer in the Management of Type 2 Diabetes in Indian Context? Asian Journal of Diabetology. 2022: 5(3):32-37.
14. Tarenia SS, Chakraraborty P Das N, Baidya A. Acromegaly - Case Series. tip [Internet]. 2023Feb.8 [cited 20230 ct.12]; 76 (0 1):34 -9. Available https://articles.theindianpractitioner.com/index.php/tip/article/view/1485.
15. Baidya A et al. Prevalence and Severity of Chronic Obstructive Pulmonary Disease in People with Type 2 Diabetes: Cross-Sectional Study. Clinical Diabetology, July, 2023; DOI: 10.5603/cd.95828